MedTrace Logo

Bioactive Knee Sleeves After ACL Reconstruction

NCT07707128 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 35

Last updated 2026-07-16

No results posted yet for this study

Summary

This trial is studying the effectiveness of a bioactive knee sleeve to improve swelling and range of motion in the early postoperative ACL reconstruction.

Conditions

  • Anterior Cruciate Ligament (ACL) Reconstruction Surgery

Interventions

DEVICE

Bioactive Knee Sleeve

This is a bioactive sleeve that produces a photobiomodulation (PBM) effect via low-lever laser therapy (LLLT), where light is transmitted at various wavelengths that trigger biochemical changes optimal for reduced inflammation and pain.

Sponsors & Collaborators

  • Challenger Health, LLC

    collaborator UNKNOWN

  • Western Kentucky Heart and Lung Research Foundation and Educational Trust

    lead OTHER

Principal Investigators

  • Melinda Joyce, Doctor of Pharmacy · Western Kentucky Heart and Lung Research Foundation and Educational Trust

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
16 Years
Max Age
40 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-08-19
Primary Completion
2025-02-01
Completion
2026-02-01
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07707128 on ClinicalTrials.gov